Medtrade is a global medical device company based in the UK providing R&D, advanced manufacturing, regulatory and marketing to provide an unparalleled and full service support for distribution partners across the world.
We dedicate ourselves to saving and improving people’s lives by tackling the global biofilm challenge, support the healing of chronic wounds and stop bleeding through continual product innovation using patented and evidence-based technologies
Medtrade provides a broad range of market leading patented, innovative wound management solutions as a private label or under the Medtrade AVARUS™ brand. We provide technical, research, regulatory, supply chain and commercial support to help our partners grow and develop their business.
moreMedtrade is a world-leading product innovator, developer and manufacturer of the Celox™ product range. We are committed to finding the fastest and most effective ways to stop bleeding, seal wounds and control infection in burn injuries - providing military medics, and tactical and civilian emergency responders the very best chance of saving a life, when faced with the unthinkable.
moreOMNI-STAT® and Celox™ are powerful hemostatic agents for medical professionals designed to stop difficult to control bleeding on a broad variety of wounds in a diverse patient population. Hemostatic agents can be used for various applications across the hospital.
moreMedtrade has a dedicated and focused product innovation team committed to finding solutions for global health challenges such as biofilm, treatment of chronic wounds, pressure injuries, infection prevention and bleeding control
morePosted: 9th May 2022 | Medtrade News
Monday, May 9th, 2022 New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists...
This website uses Cookies to improve your browsing experience and to help with our marketing. You can read more about removing Cookies here: Cookie Policy
I'm fine with thisSimply complete our form below and we’ll get in touch very soon to answer your enquiry.
